Using AI to improve the quality of upper gastrointestinal endoscopy reports
A Prospective, Single-arm, Single-center Observational Study to Evaluate the Clinical Effectiveness of an Intelligent Reporting System for the Upper Gastrointestinal Endoscopy
This study tests whether using an AI tool to help write reports during upper gastrointestinal endoscopies can make those reports better than the usual way of doing it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Renmin Hospital of Wuhan University Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT05851716 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of an AI-based reporting system designed to enhance the quality of reports generated during upper gastrointestinal endoscopy. Participants will undergo routine endoscopy, where junior endoscopists will draft reports with AI assistance, while senior endoscopists will use traditional methods. The study aims to determine if the AI system can improve the completeness of these reports compared to standard practices.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are scheduled for screening, surveillance, or diagnostic upper gastrointestinal endoscopy.
Not a fit: Patients with contraindications for endoscopy, active gastrointestinal bleeding, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and comprehensive endoscopy reports, ultimately improving patient care.
How similar studies have performed: While the use of AI in medical reporting is a growing field, this specific application in upper gastrointestinal endoscopy reporting is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 18 years 2. Aim to undergo screening, surveillance, and diagnosis 3. Undergo sedated EGD 4. Able to read, understand, and sign informed consent Exclusion Criteria: 1. EGD contraindications 2. Not suitable for sedated endoscopy after anaesthesia evaluation 3. Biopsy contraindications 4. Active upper gastrointestinal bleeding or emergency oesophagogastroduodenoscopy (EGD) 5. Pregnancy 6. Upper gastrointestinal surgery or residual stomach 7. Not suitable for recruitment after investigator evaluation because of other high-risk conditions
Where this trial is running
Wuhan, Hubei
- Renmin Hospital of Wuhan University — Wuhan, Hubei, China (Recruiting)
Study contacts
- Study coordinator: Honggang Yu, MD
- Email: yuhonggang1968@163.com
- Phone: +8613871281899
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.